Comments to NIH: ODS Strategic Plan 2022-2026 Share page: CHPA appreciates the opportunity to provide comments on NIH ODS strategic plan 2022-2026. Download Document Issues: Dietary Supplements Ingredient Safety Labeling Related Posts Press Releases and Statements CHPA Responds to FDA Draft Guidance on NDIN Master Files for Dietary Supplements Apr 3, 2024 Comments Comments Regarding Conducting Remote Regulatory Assessments Questions and Answers, Draft Guidance for Industry Mar 26, 2024 Press Releases and Statements CHPA Responds to Durbin Letter Calling for DSHEA Modernization Mar 18, 2024